Detection of BCR/ABL Translocation in Bone Marrow Derived Mesenchymal Stem Cells in Egyptian CML Patients.
BACKGROUND
Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of hematopoietic stem cells. It is characterized at the cytogenetic level by Philadelphia (ph) chromosome and at the molecular level by the BCR/ABL gene rearrangement. Bone marrow derived mesenchymal stem cells (MSCs) are pluripotent stem cells that can differentiate into several mesenchymal tissues.


OBJECTIVE
To observe the biological characteristics of MSCS from CML patients and to determine whether MSCs harbor the abnormal BCR/ABL translocation similar to CML bone marrow cells.


METHODS
Characterized MSCs were isolated from 12 newly diagnosed Philadelphia positive untreated CML patients.


RESULTS
MSCs can be readily isolated from CML marrow and exhibit major expansion. Flow cytometry analysis revealed the typical MSC phenotype. Moreover; MSCs do not harbor the BCR/ABL translocation confirmed by karyotype and real time PCR.


CONCLUSIONS
MSCs from CML patients express the typical MSC phenotype; and do not express the BCR/ABL gene. Since; MSCs are able to support engraftment of hematopoietic stem cells in stem cell transplantation(SCT) as well as suppress alloreactive T cells causing graft versus -host disease, this current study provides evidence that in a SCT setting of CML patients, autologous MSCs could be a source of stem cell support in future cell therapy applications.
Department of Clinical and Chemical Pathology, Faculty of Medicine, Cairo University, Cairo, Egypt.
Taghrid Mohamed
TM
Gaafar
Department of Clinical and Chemical Pathology, Faculty of Medicine, Cairo University, Cairo, Egypt.
Inas Ismail
II
Raafat
Department of Clinical and Chemical Pathology, National Research Center, Egypt.
Azza Ahmed
AA
Aly
Department of Clinical and Chemical Pathology, National Research Center, Egypt.
Nagwa Abd El-Ghaffar
NA
Mohamed
Department of Clinical and Chemical Pathology, Faculty of Medicine, Cairo University, Cairo, Egypt.
Reem Jan
RJ
Farid
Department of Clinical and Chemical Pathology, National Research Center, Egypt.
Neveen Ezzat
NE
Saad
Department of Clinical and Chemical Pathology, Faculty of Medicine, Cairo University, Cairo, Egypt.
Rabab
R
El-Hawary
Department of Clinical and Chemical Pathology, National Cancer Institute, Cairo, Egypt.
Naglaa
N
Mostafaa
Department of Clinical and Chemical Pathology, National Research Center, Egypt.
Mirhan Mohamed
MM
Ahmed
Chronic myeloid leukemia; Philadelphia chromosome; mesenchymal stem cell